HYBRID EVENT: You can participate in person at Glasgow, UK or Virtually from your home or work

Tentative Program

Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 1–2 March 2027
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 5 SDGs SDGs 3, 4, 9, 16 and 17
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

1 MAR 2027 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Advancements in Drug Discovery Technologies
    39
    Track Overview

    This track will explore the latest innovations in drug discovery technologies, including high-throughput screening and computational drug design. Participants will discuss how these advancements can enhance the efficiency and efficacy of pharmaceutical research.

    Track 02
    Pharmacology and Therapeutic Innovations
    34
    Track Overview

    This session focuses on the evolving landscape of pharmacology and its implications for therapeutic innovations. Researchers will present novel pharmacological approaches that aim to improve patient outcomes and safety.

    Track 03
    Medicinal Chemistry: Challenges and Opportunities
    39
    Track Overview

    This track will address the current challenges faced in medicinal chemistry, including drug resistance and formulation issues. Experts will share their insights on emerging strategies and technologies that can overcome these obstacles.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Clinical Pharmacy and Patient-Centered Care
    34
    Track Overview

    This session emphasizes the role of clinical pharmacy in enhancing patient-centered care. Discussions will highlight best practices and innovative approaches to optimize medication management in diverse healthcare settings.

    Track 05
    Formulation Science in Drug Development
    39
    Track Overview

    This track will delve into the critical aspects of formulation science and its impact on drug development. Participants will examine case studies that illustrate the importance of formulation strategies in achieving therapeutic efficacy.

    Track 06
    Pharmaceutical Sciences: Bridging Research and Practice
    34
    Track Overview

    This session aims to bridge the gap between pharmaceutical sciences research and clinical practice. Presentations will focus on translational research efforts that facilitate the application of scientific findings to improve patient care.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
Day 02

Keynote, Technical Sessions & Awards

2 MAR 2027 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Drug Safety and Risk Management
    316
    Track Overview

    This track will cover essential topics related to drug safety and risk management in the pharmaceutical industry. Experts will discuss regulatory frameworks, post-marketing surveillance, and strategies to mitigate adverse drug reactions.

    Track 08
    Innovations in Pharmacy Practice
    34
    Track Overview

    This session will highlight innovative practices in pharmacy that enhance service delivery and patient engagement. Participants will share successful models and interventions that have improved pharmacy practice outcomes.

    Track 09
    Pharmacogenomics and Personalized Medicine
    34
    Track Overview

    This track will explore the role of pharmacogenomics in the development of personalized medicine. Discussions will focus on how genetic variations influence drug response and the implications for tailored therapeutic strategies.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Emerging Trends in Pharmaceutical Research
    39
    Track Overview

    This session will examine emerging trends and future directions in pharmaceutical research. Researchers will present cutting-edge studies that address current challenges and opportunities in drug discovery and development.

    Track 11
    Collaborative Approaches in Drug Development
    317
    Track Overview

    This track will focus on the importance of collaboration among academia, industry, and regulatory bodies in drug development. Participants will discuss successful partnerships that have accelerated the drug discovery process.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure 16 Peace, Justice and Strong Institutions 17 Partnerships for the Goals

Be Part of ISPDD-27

Submit your research or complete your conference registration.